Background: Functional heterogeneity in the tumor necrosis factor a (TNF-a) gene may be responsible for the TNF-a response in infectious and autoimmune diseases. Recently, the TNF-238 promoter polymorphism was observed as being associated with a more destructive disease in rheumatoid arthritis (RA). To determine the relation between TNF-238 and disease progression, the extent of joint destruction in a cohort of 101 RA patients followed for 12 years was analyzed. Furthermore, we have attempted to link this polymorphism to TNF-a gene transcription in monocytes and lymphocytes in
Introduction
The cytokine tumor necrosis factor (TNF) a has an essential role in the inflammatory response. In dysregulated inflammation, such as rheumatoid arthritis (RA), TNF-a is directly implicated in the pathogenesis. The most compelling evidence stems from studies in which remarkable clinical benefit was observed in RA patients treated with anti-TNF-a antibodies (1, 2) .
Since the consequence of TNF-a production is believed to depend on the timing, localization, and extent of its release, the tight control of TNF-a production may be critical to mount a proper immune response. In support of this idea, deregulated TNF-a expression in transgenic mice led to the induction of a symmetric polyarthritis similar to RA (3) . Moreover, mice with one of the TNF alleles deleted (TNF '-) showed increased susceptibility to high-dosage lipopolysaccharide (LPS) lethality and infectious agents, which suggest the biological consequences of differences in gene dosage (4, 5) .
The regulation of TNF-a production is celltype specific and tightly controlled at multiple levels including transcription, mRNA stabilization, translation, and precursor processing. Sequences at the 5' end of the gene are crucial for the control of transcription (6, 7) . Sequences in the 3' UTR are implicated in regulating mRNA stability and translational efficiency of the mRNA (reviewed in refs. 8, 9) .
The search for genetic heterogeneity within the TNF-a gene has disclosed several polymorphisms in the 5' regulatory region. In RA, genetic factors influence the extent of joint damage. RA patients who are DR4 positive suffer from a more severe disease course than those who are DR4 negative (10) . The TNF-a promoter polymorphism at position -238 (11) has been associated with disease severity independent of HLA-DR. In a case-control study, a relationship was found between the TNF-238GG genotype and a more destructive disease course and earlier disease onset in RA (12, 13) . Consistent with these findings, the TNF-238GA genotype tends to correlate with less severe disease in multiple sclerosis (14) . In systemic lupus erythematosus, the TNF-238AA genotype was found to be a marker of a particular clinical subtype (15) . Furthermore, associations of the TNF-238 polymorphism with juvenile onset psoriasis and psoriatic arthritis (16) , the occurrence of scarring thrachoma (17) , and susceptibility to alcoholic steatohepatitis have
The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the been reported (18) . Considering the location of this polymorphism in a region involved in TNF-a gene transcription and its association with disease, we hypothesized that the -238 G to A transition might influence TNF-a mRNA expression and as a result, facilitate deregulation of the cytokine network, thereby influencing the disease process. In order to extend the association between the -238GG genotype and joint destruction, the relation between the TNF-238 promoter polymorphism and the progression of joint erosions was determined in a prospective study. To determine whether the -238 polymorphism has functional relevancy, we measured the activity of the allelic TNF-a promoters in their capacity to drive reporter gene expression in transient transfection experiments.
Patients, Materials, and Methods
Patients and Healthy Controls From a previously reported cohort study (19) (20) . Five RA patients were heterozygous -238GA and 96 RA patients were -238GG. Clinical data concerning the presence or absence of increased serum levels of rheumatoid factor were collected from the patients' files. Radiographs of hands and feet were taken at study entry and after 3, 6 , and 12 years. The hand and foot radiographs were scored separately according to the van der Heijde modification of Sharp's method (21) Isolation of genomic DNA, typing of HLA-DR4, and assessment of TNF-a genotype was carried out as described previously (12) .
DNA Constructs
Generation of the wild-type TNF-a promoter-CAT construct TNF-238G/CAT containing the TNF-a promoter fragment from -598 to +108 has been described previously (22 .V
TNli&Wff in a luminometer using the Dual-Luciferase reporter assay system (measuring both firefly and Renilla luciferase) as directed by the manufacturer (Promega). The T cell line Jurkat and B cell line Raji were grown and transfected with TNF-a-CAT test plasmids as previously described (22) . Twenty-four hours after transfection, Raji B cells were activated with PMA (0.05 ,ug/ml) and Jurkat T cells with a combination of PMA (0.01 jig/ml) and aCD3 monoclonal antibody (CLB-T3/4.1; 0.25 ,g/ml, kindly provided by L. Aarden, CLB Amsterdam). Cells were harvested 24 h later and CAT assays were carried out as previously described (22) . As a control of transfection efficiency, luciferase activity of a cotransfected RSV-luciferase plasmid was measured in a luminometer.
Statistical Analysis
The difference between the -238GA and the -238GG group regarding the rate of joint damage as judged by the Sharp score was calculated by regression analysis using mixed model ANOVA.
Pair-wise linkage disequilibrium analysis was carried out according to the maximum likelihood procedure, with the iterative process outlined by Hill (27) Table 2 ). The data revealed that approximately 12% (4 out of 33) of individuals carrying the -238A allele are also positive for the -376A allele, whereas individuals who carried the -376A allele were always carrying the -238A allele. Haplotype analysis according to Hill (27) (Fig. 2) . For analysis of TNF-a promoter activity in a T and B cell background, Jurkat and Raji cells were transiently transfected with the allelic TNF-a promoter/enhancer constructs driving the CAT reporter gene and stimulated with aCD3/PMA and PMA, respectively. CAT activity of the constructs was expressed as the relative activity of the construct with the highest activity (100%) in each experiment. The different TNF-a promoter variants did not affect constitutive or stimulated TNF-a gene expression in Jurkat and Raji cells (Fig. 3) .
In conclusion, these results reveal no significant differences in transcriptional activity between the TNF-238G, TNF-238A, and TNF-238A/-376A ferent batches of plasmid DNA. The luciferase constructs were always tested simultaneously. Luciferase activity of the constructs is expressed as the relative activity of the plasmid with the highest activity (100%) reached at 4 hr after stimulation in each experiment. Relative luciferase activities (± SD) were averaged and plotted in histograms as depicted.
promoter/enhancers in U937, Mono Mac 6, Jurkat T, and Raji B cells.
Discussion
The major histocompatibility complex (MHC) region contains genes whose products fulfil a role in the immune response. The importance of this region is exemplified by the long list of pathologies linked to MHC alleles. Previously, we identified the TNF-238GG genotype as a genetic factor that contributes to radiologically detected erosions in RA in a case-control study (12) . This study was retrospective and it measured only one parameter (the number of erosive joints in the hands after 3 years). Therefore, we determined the progression of joint damage in a prospective cohort of 101 RA patients. The rate of joint damage in -238GA patients was lower than that in the -238GG patients, independent of HLA-DR4. (32) to determine whether upstream TNF-a sequences could influence the transcriptional activity of -238 alleles. In analogy to the -598/+108 reporter gene constructs, the -1173/+130 -238A and -238G driven reporter gene expression was found to be essentially equivalent when assayed by transient transfection into Mono Mac 6 and the murine macrophage cell line ANA-1 (data not shown). This suggests that the TNF-238 polymorphism neither contributes by itself nor synergizes with the upstream region to influence TNF-a gene transcription.
In this study, we have tested the allelic promoter constructs in cell lines representative of monocytes and T and B cells in combination with the standard in vitro TNF-a-inducing stimuli LPS/PMA, aCD3/PMA, and PMA, respectively. A functional difference between an A and a G at position -238 might become prominent with a physiological TNF-a-inducing stimulus, which may be different from the stimuli used in this study. In this respect, it is worth mentioning that the association between HLA-DR alleles and TNF-a producer phenotypes was assigned with standard in vitro TNF-a-inducing stimuli similar to those we used (33, 34) . Hence, application of these stimulation conditions in reporter gene studies may be expected to disclose a functional TNF-a gene polymorphism.
TNF-a is known to boost its own production by a positive feedback on its own gene expression (35) . Through this mechanism, a minor difference in the initial TNF-a response is amplified in an in vivo system. This phenomenon is exemplified in studies performed with mice heterozygous for a deletion of the TNF-a gene (TNF+/ ), which revealed that a small reduction of 50% of the initial TNF-a gene expression gives a phenotype due to a nonlinear response in TNF-a levels (4, 5) . In line with this reasoning, the possibility that the presence of relatively small, nonsignificant differences in allelic activity might be enough to elicit a biological effect in an in vivo system cannot be excluded. It is therefore relevant to note that the absence of a direct effect of TNF-238 on TNF-a enhancer/promoter activity is in agreement with a previous study showing that monocytes derived from TNF-238GA healthy individuals did not significantly differ in their in vitro TNF-a production capacity compared to that of TNF-238GG healthy individuals (36) .
In addition to the TNF-238 variant, other TNF-a promoter polymorphisms may have a transcriptional effect. The most well studied at position -308 (37) is found to be associated with severe forms of infectious diseases (38, 39) . However, conflicting data exist about its functionality (22, 40, 41, 42) .
In addition to putative functional relevant promoter/enhancer polymorphisms, other mechanisms may account for differential TNF-a production. Both in cis and in trans processes may be involved. However, besides polymorphism in the 5' part of the TNF-a gene, heterogeneity in the 3' UTR, which might indicate in cis (post) translational interference in TNF-a production, has not been reported. Alternatively, it is also possible that tightly linked and yet unidentified alleles at other loci modify the production or activity of TNF-a. Since TNF-a production has been suggested as being MHC associated, the major component responsible for differential TNF-a production may reside within the MHC locus. This locus harbors a number of genes whose products are (in)directly involved in the biosynthesis of TNF-a. A candidate gene is the SAPK-2 (stress-activated protein kinase-2) gene encoding a kinase involved in the regulation of cytokine production (43) . Other candidates are the I-KB/NF-KB-like genes IKBL (44) and G9a (45) , which may play crucial roles in inducible transcriptional gene activation. Mutations affecting the expression of these genes or the activity of their gene products could have an impact on the expression of a wide range of cytokine genes, including the gene encoding TNF-a, and consequently contribute to disease susceptibility and/or determine disease outcome.
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